![]() SARS-CoV-2 Mpro-IN-9 structure
|
Common Name | SARS-CoV-2 Mpro-IN-9 | ||
---|---|---|---|---|
CAS Number | 2754370-99-3 | Molecular Weight | 346.34 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H14N2O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of SARS-CoV-2 Mpro-IN-9SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1]. |
Name | SARS-CoV-2 Mpro-IN-9 |
---|
Description | SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.085 μM (SARS-CoV-2), EC50: 1.10 μM (viral replication)[1] |
References |
Molecular Formula | C20H14N2O4 |
---|---|
Molecular Weight | 346.34 |